Saccharomyces cerevisiae harbors
BAT1 and
BAT2 paralogous genes that encode branched chain aminotransferases and have opposed expression profiles and physiological roles . Accordingly, in primary nitrogen sources such as glutamine,
BAT1 expression is induced, supporting Bat1-dependent valine–isoleucine–leucine (VIL) biosynthesis, while
BAT2 expression is repressed. Conversely, in the presence of VIL as the sole nitrogen source,
BAT1 expression is hindered while that of
BAT2 is activated, resulting in Bat2-dependent VIL catabolism. The presented results confirm that
BAT1 expression is determined by transcriptional activation through the action of the Leu3–α-isopropylmalate (α-IPM) active isoform, and uncovers the existence of a novel α-IPM biosynthetic pathway operating in a
put3Δ mutant grown on VIL, through Bat2-Leu2-Leu1 consecutive action. The classic α-IPM biosynthetic route operates in glutamine through the action of the leucine-sensitive α-IPM synthases. The presented results also show that
BAT2 repression in glutamine can be alleviated in a
ure2Δ mutant or through Gcn4-dependent transcriptional activation. Thus, when
S. cerevisiae is grown on glutamine, VIL biosynthesis is predominant and is preferentially achieved through
BAT1; while on VIL as the sole nitrogen source, catabolism prevails and is mainly afforded by
BAT2.